Astellas Pharma Inc. (ALPMY)
OTCMKTS · Delayed Price · Currency is USD
10.87
+0.06 (0.56%)
Oct 9, 2025, 3:58 PM EDT
Astellas Pharma Market Cap
Astellas Pharma has a market cap or net worth of $19.43 billion as of October 9, 2025. Its market cap has decreased by -13.78% in one year.
Market Cap
19.43B
Enterprise Value
23.83B
Revenue
13.48B
Ranking
n/a
PE Ratio
34.37
Stock Price
$10.87
Market Cap Chart
Since January 14, 1992, Astellas Pharma's market cap has increased from 6.96B to 19.43B, an increase of 179.11%. That is a compound annual growth rate of 3.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 19.43B | 11.19% |
| Dec 30, 2024 | 17.48B | -18.50% |
| Dec 29, 2023 | 21.44B | -22.67% |
| Dec 30, 2022 | 27.73B | -7.87% |
| Dec 30, 2021 | 30.10B | 5.02% |
| Dec 30, 2020 | 28.66B | -10.92% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 314.22M |
| American Oncology Network | 274.14M |
| Silence Therapeutics | 242.78M |